Asymmetric total synthesis of buprenorphine and dihydroetorphine

[1]  G. Henriksen,et al.  NMR Analysis of a Series of 6,14‐Ethenomorphinan Derivatives as PET Precursors and Reference Substances** , 2021, ChemistrySelect.

[2]  Sonali S. Bharate,et al.  Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis. , 2018, Journal of medicinal chemistry.

[3]  F. Sato,et al.  Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli , 2016, Nature Communications.

[4]  J. Nielsen,et al.  Yeast cell factories on the horizon , 2015, Science.

[5]  C. Smolke,et al.  Complete biosynthesis of opioids in yeast , 2015, Science.

[6]  Yi Li,et al.  Morphinan biosynthesis in opium poppy requires a P450-oxidoreductase fusion protein , 2015, Science.

[7]  Darcy C Burns,et al.  Stereochemical inversion of (S)-reticuline by a cytochrome P450 fusion in opium poppy. , 2015, Nature chemical biology.

[8]  Zachary N. Russ,et al.  An enzyme-coupled biosensor enables (S)-reticuline production in yeast from glucose. , 2015, Nature chemical biology.

[9]  C. Smolke,et al.  A microbial biomanufacturing platform for natural and semi-synthetic opiates , 2014, Nature chemical biology.

[10]  G. Hanks,et al.  A systematic review of oxycodone in the management of cancer pain , 2011, Palliative medicine.

[11]  S. Husbands,et al.  Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse. , 2003, Mini reviews in medicinal chemistry.

[12]  S. Robinson.  Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. , 2006, CNS drug reviews.

[13]  Y. Morimoto,et al.  Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects. , 2006, CNS drug reviews.

[14]  G. W. Kirby.  Biosynthesis of the Morphine Alkaloids , 1967, Science.